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Abstract
Background: The reasons for socioeconomic inequity in stroke mortality are not well understood. The aim of this
study was to explore the role of ischemic stroke care-pathways on the association between education level and
one-year survival after hospital admission.
Methods: Hospitalizations for ischemic stroke during 2011/12 were selected from Lazio health data. Patients’
clinical history was defined by retrieving previous hospitalizations and drugs prescriptions. The association between
education level and mortality after stroke was studied for acute and post-acute phases using multilevel logistic
models (Odds Ratio (OR)). Different scenarios of quality care-pathways were identified considering hospital
performance, access to rehabilitation and drug treatment post-discharge. The probability to survive to acute and
post-acute phases according to education level and care-pathway scenarios was estimated for a “mean-severity”
patient. One-year survival probability was calculated as the product of two probabilities. For each scenario, the
1-year survival probability ratio, university versus elementary education, and its Bootstrap Confidence Intervals
(95 % BCI) were calculated.
Results: We identified 9,958 patients with ischemic stroke, 53.3 % with elementary education level and 3.2 % with
university. The mortality was 14.9 % in acute phase and 14.3 % in post-acute phase among survived to the acute
phase. The adjusted mortality in acute and post-acute phases decreased with an increase in educational level
(OR = 0.90 p-trend < 0.001; OR = 0.85 p-trend < 0.001). For the best care-pathway, the one-year survival probability
ratio was 1.06 (95 % BCI = 1.03–1.10), while it was 1.17 (95 % BCI = 1.09–1.25) for the worst.
Conclusions: Education level was inversely associated with mortality both in acute and post-acute phases.
The care-pathway reduces but does not eliminate 1-year survival inequity.
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Background
The relationship between risk of dying from a stroke and
Socio-Economic Status (SES), identified by income or
education level, has been extensively investigated [1–3].
Most of the studies have shown an inverse association be-
tween stoke incidence/mortality and SES [4]. However,
the mechanisms by which SES affects stroke mortality
have not been established. The social gradient observed
may be associated with worse lifestyles/clinical conditions
that are typically observed in groups of people with a rela-
tively low socioeconomic position; [5, 6] however, several
studies have also suggested a potential association be-
tween SES and quality of care [7–10]. Evidence exists
demonstrating that early management in a specialist
environment for acute stroke patients is associated with
health outcomes; however, conflicting results exist regard-
ing the beneficial effects of pharmacological treatments in
acute and post-acute phases [11]. Early and post-acute
rehabilitation is clearly recommended, and optimal strat-
egies for patients with various levels of neurological
impairment after stroke need to be elucidated [11]. The
limits of randomized controlled trial and the need for
observational research to evaluate the real-life effective-
ness of health interventions have recently been strongly
emphasized [12].
The aims of this study were as follows: to analyze the
effect of SES on short- and long-term mortality after
acute ischemic stroke; to measure the real-life effective-
ness of the acute and post-acute pathways of care for
patients with acute ischemic stroke; and to explore the
role of the care-pathway, both for the acute and post-
acute phases, on the association between education level




A health data repository for the Lazio region in Italy
(approximately 5 million residents) is available. It con-
nects health information for each individual registered
in the Regional Health System (approximately 97 % of
residents) using a unique and anonymous subject
identifier. Specifically, the available health information
present in this system includes hospitalizations, emer-
gency visits, rehabilitation, drug prescriptions and
mortality.
Study population
From the Lazio health data warehouse, we identified
a cohort of patients, all aged over 35 years old, dis-
charged from the hospital with a diagnosis of ische-
mic stroke between January 1st 2011 and December
31st 2012 (ICD-9-CM codes: 433.x1, 434.×1, 436) and
survivors to at least 1 day post-admission. We
excluded patients with a previous hospitalization for
stroke, either hemorrhagic or ischemic, in the 2 years
previous to admission.
Patient characteristics
For each subject, the socio-demographic factors, includ-
ing age, sex and educational level, recorded during the
ischemic stroke hospitalization were considered. Patient
clinical history was defined by retrieving specific condi-
tions recorded during hospitalizations or emergency
visits in the 2 years previous to the index stroke admis-
sion and by taking into account concomitant conditions
with the index admission. The conditions retrieved were
diabetes, chronic obstructive pulmonary disease, hyper-
tension, previous myocardial infarction, heart failure,
rheumatic heart disease, cardiomyopathy acute endocar-
ditis and myocarditis, other heart conditions, conduction
disturbances and arrhythmias, cerebrovascular diseases,
vascular diseases, obesity-dyslipidemia, blood disorders,
chronic digestive disease, chronic renal diseases, and
cancer.
To better define the clinical profiles of the patients, we
also assessed the use of drugs in the 6 months prior to
admission: cardiac therapies, anti-diabetic drugs, antiplate-
let therapies, anticoagulants, antihypertensive drugs, di-
uretics, beta-blocking agents, calcium channel blockers,
angiotensin-converting-enzyme inhibitors, and angioten-
sin II antagonists or statins.
Outcomes
Two different post-stroke outcomes were defined: 2–30
days mortality for the acute-phase and 31–365 days
mortality for the post-acute phase.
Care-pathways
To identify different scenarios of quality care-pathways in
the acute phase, we classified hospital performance con-
sidering the available literature. Hospitals with a stroke
unit or a team of expert neurologists were defined as “high
performance” [9, 13–15], while the hospitals with a low
volume of stroke admissions (<100 in the study period)
were defined as “low performance” [7, 16]. All others were
classified as “medium performance”. The care-pathway
during the post-acute phase was defined on the basis of
access to rehabilitation or drug treatment in the 30 days
after discharge: number of antihypertensive, antithrom-
botic, or statin drugs. To reduce misclassification and het-
erogeneity of care-pathways in the post-acute phase, we
excluded patients who died within 30 days after discharge
or with a length of stay in the hospital ≥ 28 days. We
defined the best care-pathway scenario as a “hospital with
high performance, access to rehabilitation, use of all three
drugs” and the worst as a “hospital with low performance,
no access to rehabilitation, no use of drugs”.
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Statistical analysis
The association between education level and mortality
after stroke was studied for both the acute and post-
acute phases using logistic models [Odds Ratio (OR)]
and adjusting for age, sex, care-pathway and the risk fac-
tors selected by a stepwise bootstrap procedure. Using
this approach, 1000 replicated bootstrap samples were
selected from the original cohort. A bootstrap sample is
a sample of the same size as the original dataset chosen
with replacement. Thus, a given subject in the original
cohort may be selected multiple times, only once, or not
at all in a specific bootstrap sample. A stepwise proced-
ure, using thresholds of p = 0.05 for variable selection
and elimination, was applied to each replicated sample,
and only the factors selected in at least 50 % of the pro-
cedures were included in the final models. Taking into
account the variability of mortality between hospitals,
we used a multilevel approach, with hospital as 2nd
level, considering patients as repeated observations
within hospitals.
To evaluate the effect of increase of education level on
mortality, we estimate OR considering exposure as a lin-
ear variable.
The probability to survive to the acute and post-acute
phases according to education level and care-pathway
scenarios were estimated for a “mean severity” patient,
assuming for this patient the same distribution of age,
sex and mortality risk factors as observed in the cohort.
Because the survival of patients in the post-acute phase
(B) is conditioned to the survival in the acute phase (A),
the 1-year survival probability was calculated as the
product of the two probabilities: P(1-year survival) =
P(A)P(B|A).
For each scenario, the 1-year probability ratio for uni-
versity versus elementary education and its Bootstrap
Confidence Intervals (95 % BCI) were calculated. In this
sense, the bootstrap distribution represents an (approxi-
mate) nonparametric, noninformative posterior distribu-
tion for our parameter. But this bootstrap distribution is
obtained painlessly, without having to formally specify a
prior and without having to sample from the posterior
distribution. By perturbing the data, the bootstrap ap-
proximates the Bayesian effect of perturbing the parame-
ters, and is typically much simpler to carry [17].
The 1-year Probability Ratios (PRs) for the best and
worst scenarios were calculated by sex and age classes to
evaluate the potential effect of demographic factors on
the relationship among care-pathways, education level
and mortality.
Sensitivity analyses
To assess the robustness of the results, three sensitivity
analyses were carried out. To take into account the ef-
fect of the time spent in the post-acute phase, the
association between education level and mortality was
examined using an adjusted Cox model [Hazard Ratio
(HR)]. To confirm the strength of our findings, we re-
plied the main analysis on the subgroup of new drug
users. To reduce the selection bias due to the exclusion
of patients in the post-acute phase, we applied the main
analysis using the Inverse Probability Weighting (IPW).
This methodology allows to correct the analysis by
weighting the observations with the probability of being
selected. The IPW is based on the assumption that indi-
vidual information that can predict the probability of
inclusion (non-missingness) are available for the entire
study population, so that, after taking account of them,
we can make inferences about the entire target popula-
tion starting from the non-missing observations alone.
The procedure for the calculation was the following:
firstly, we considered the entire population at study and
calculated the probability of non-missing information
using a logistic regression model, where the response
was the non-missingness and the covariates are its pos-
sible predictors. The weight of each subject was given by
the inverse of the predicted probability. Then the ana-
lysis was performed only on the non-missing observa-
tions using a weighted model.
Results
We identified 9,958 patients who were hospitalized for
ischemic stroke during 2011–2012 (Fig. 1). Among
them, 8,477 (85.1 %) survived for 30 days after admis-
sion, and 5.8 % were excluded from the post-acute
phase. The overall 1-year mortality was 26.3 %.
The mean age of the cohort was 76 years, 50 % were
male, 53.3 % had an elementary education level, and 3.2 %
had a university degree (Table 1). The adjusted mortality
in the acute and post-acute phases decreased with an in-
crease in the education level (OR = 0.90 p-trend < 0.001;
OR = 0.85 p-trend < 0.001). In particular, we observed a no
statistically significant reduction in mortality of 31 % for
patients with a university-level education relative to those
with an elementary-level education in the acute phase
(OR 0.69; p.value = 0.096) and of 45 %, statistically signifi-
cant, in the post-acute phase (OR 0.55; p.value = 0.021).
Hospitals with high performance had lower mortality in
the acute phase (OR = 0.70; p.value = 0.006); this protect-
ive effect also persisted in the post-acute phase, but it was
not significant (OR = 0.82; p.value = 0.106).
Access to rehabilitation post-discharge did not change
the long-term mortality (OR = 0.93; p.value = 0.402). For
each drug that was subtracted from “complete” drug
treatment, we observed an increase in mortality in the
post-acute phase (OR = 1.49; p-trend < 0.001; data not
shown).
Figure 2 shows the 1-year probability to survive by edu-
cation level according to the best and worst care-pathway
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Fig. 1 Number of patients and mortality in the acute and post-acute phases
Table 1 Determinants of mortality after stroke for the acute and post-acute phases
Acute phase 2–30 days (N = 9958) Post acute phase 31–365 days (N = 7984)
% of patients ORadj
a p value % of patients ORadj
a p value
Sex
Women vs Men 50.0 1.18 0.010 47.3 1.02 0.824
Age in years
35–65 18.1 1.00 <.0001c 21.6 1.00 <.0001c
66–75 23.2 2.45 <.0001 25.9 2.24 <.0001
76–85 38.2 5.20 <.0001 37.7 3.75 <.0001
85+ 20.4 11.17 <.0001 14.8 7.96 <.0001
Education level
Elementary 53.3 1.00 0.038c 49.5 1.00 0.101c
Medium 28.7 0.88 0.132 30.7 0.87 0.123
High 14.8 0.71 0.004 16.4 0.81 0.092
University 3.2 0.69 0.096 3.4 0.55 0.021
Care-Pathway
Hospital Performance
Medium 38.5 1.00 0.025c 37.6 1.00 0.523c
High 41.6 0.70 0.006 43.9 0.82 0.106
Low 19.9 1.21 0.156 18.6 0.99 0.917
Access to rehabilitation 33.0 0.93 0.402
Treatment post-dischargeb
Three drugs 23.0 1.00 <.0001c
Two drugs 27.7 1.58 <.0001
One drugs 15.5 2.15 <.0001
No drugs 33.7 3.43 <.0001
p-value (test di Wald) 0.014 0.029
aadjusted for risk factors selected from clinical history and previous use of drugs
bnumber of antihypertensive, antithrombotic, or statin drugs
cglobal Chi-Square test
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for a “mean severity” patient. For the best care-pathway,
the 1-year probability ratio of a university education ver-
sus an elementary education was 1.06 (95 % BCI = 1.03–
1.10), whereas it was 1.17 (95 % BCI = 1.09–1.25) for the
worst care-pathway.
The relationships among care-pathway, education
level and 1-year survival were investigated for demo-
graphic characteristics (Fig. 3). The relationship did
not change between men and women; for younger pa-
tients, the effect of the care-pathway on the associ-
ation between education level and 1-year probability
of survival was reduced (best care-pathway: PR = 1.02
vs 1.06; worst care-pathway: PR = 1.05 vs 1.17). How-
ever, for older patients, the effect was accentuated
(best care-pathway: PR = 1.17 vs 1.06; worst care-
pathway: PR = 1.39 vs 1.17).
The three sensitivity analyses confirmed the main
results. In particular, in the post-acute phase, the ad-
justed risk of mortality for patients with a university
education in respect to those with an elementary
education was as follows: HR = 0.55 with a p-value of
0.012 using the Cox model and OR = 0.40 with a p-
value of 0.010 applying the analysis for new users
only. Finally, when we applied inverse probability
weighting, we obtained that the patients excluded in
post-acute phase were older, with a higher presence
of comorbidities, such as diabetes and heart failure,
and a greater use of diuretics. In this sub-analysis the
1-year probability ratio university versus elementary
education was 1.03 for the best care-pathway and
1.11 for the worst care-pathway.
Discussion
We found a negative association between education level
and mortality after hospital admission for ischemic
stroke both in the acute and post-acute phases. Patients
who experienced the best care-pathway, in terms of a
high-performance hospital and access to rehabilitation
and drug treatment, had a higher 1-year survival. Among
the patients who were treated with the best care-
pathway, the socioeconomic associated differential in
mortality was lower than among those patients who
received the worst care-pathway.
The inverse association between education level and
stroke mortality that was observed in our study is con-
sistent with a recent review in which the majority of
studies, if not all, showed similar results [4]. The mecha-
nisms by which SES affects stroke mortality are not well
understood. Differential exposure to behavioral risk fac-
tors, particularly smoking and obesity, have been shown
Fig. 2 One-year survival probability for education level according to best and worst care-pathways for a “mean severity” patient.□ Best care-pathway.
PRUvsE* = 1.06 [1.03 – 1.10]. Worst care-pathway. PRUvsE* = 1.17 [1.09 – 1.25]. * PRUvsE = Probability Ratio of a University education versus an Elementary
education. Note: Box plots represent the 1000 simulations performed to obtain the 95 % BCI of the 1 one-year survival probability.
The 95 % BCI correspond to the ends of the whiskers
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to play an important mediating role in the social in-
equality that exists in cardiovascular disease [6, 18, 19].
However, some studies have shown that adjusting for
several risk factors did not explain the entire association
between stroke and SES [20, 21]. Our study suggests that
this differential is dependent, at least in part, on the
care-pathway. Other studies have proposed this theory,
but it remains controversial [4, 7–10, 22]. In the USA,
patients with relatively high SES were more likely to re-
ceive post-acute stroke rehabilitation [4], while in the
UK, patients with stroke who were from more deprived
areas were less likely to receive a brain scan on the same
day of admission [4]. A recent study in China reported
that 2,283 patients showed a reduced level of antithrom-
botic therapy after stroke for disadvantaged people [4].
In a nation-wide study on 14,545 patients in Denmark,
low-income stroke patients were less likely to receive an
integrated pattern of care compared with high-income
patients [9].
In the present study, we tested the role of the care-
pathway in the association between education level and
survival after stroke. To measure the various care-
pathways, we considered data from the literature [7–9,
11, 13–16]. A wealth of evidence exists demonstrating
the efficacy of early treatment in specialist care units at
the hospital level (Stroke Unit), in which a multidiscip-
linary team cooperates to reduce the impact of neuro-
logical deficits and systemic metabolic impairment of
patients who suffer an acute stroke [11]. Moreover, it
has been shown that facilities with a large amount of ex-
perience and high patient volumes are associated health
outcomes [7, 16]. In contrast, the optimal pharmaco-
logical strategies for acute ischemic stroke remain under
debate. In the majority of cases, ischemic stroke is
Fig. 3 One-year survival probability by education level according to the best and worst care-pathway for men, women, younger (35–65) and
older (85+) patients. a: Best care-pathway PRUvsE* = 1.06 [1.03 – 1.09] Worst care-pathway PRUvsE* = 1.16 [1.09 – 1.24]. b:
Best care-pathway PRUvsE* = 1.07 [1.03 – 1.10] Worst care-pathway PRUvsE* = 1.17 [1.09 – 1.25]. c: Best care-pathway PRUvsE* = 1.17
[1.08 – 1.25] Worst care-pathway PRUvsE* = 1.39 [1.19 – 1.61]. d: Best care-pathway PRUvsE* = 1.02 [1.01 – 1.03] Worst
care-pathway PRUvsE* = 1.05 [1.03 – 1.08]. * PRUvsE = Probability Ratio of a University education versus an Elementary education
Belleudi et al. BMC Public Health  (2016) 16:408 Page 6 of 8
caused by a blood clot blocking an artery in the brain.
Thus, anticoagulant drugs may have a beneficial effect.
The NICE guidelines recommend the use of both anti-
coagulant drugs and antiplatelet agents [11]. However,
the risk of bleeding is a major concern, and the routine
use of any of the currently available anticoagulants
remains controversial [23]. The use of antihypertensive
drugs and statins has been shown to have beneficial ef-
fects; however, the evidence is not conclusive [24, 25].
Both early and post-acute rehabilitation methods are con-
sidered effective in improving long-term outcomes [11].
Our study confirms the relevant role of high-performance
hospital care in the acute phase of stroke treatment
and adds to the knowledge base regarding the effect-
iveness of pharmacological treatment in the post-acute
phase. Specifically, we used an integrated approach to
measure different categories of recommended drugs
and found that a higher number of drugs was associ-
ated with a stronger effect on survival. We did not
observe any evidence of an association between re-
habilitation and survival. In this respect, it is notable
that the information on rehabilitation treatment in our
study was limited because we had no data on in-
hospital treatments or on the use of private supplies,
meaning that misclassification may have occurred.
Moreover, we did not have data on health outcomes
other than mortality, e.g., quality of life or functional
recovery, that are considered to be more specific out-
comes of rehabilitation treatment.
Despite evidence from all over the world of disparities
in survival according to SES, the identification of effect-
ive strategies to tackle SES discrepancies in health care
is a relevant challenge that may vary according to geo-
graphical and cultural context. [26, 27] No unique effect-
ive health policy has been proposed in Europe because it
depends on the different health care organization in each
country. In Italy, besides universal coverage of health
services, evidence exists of the disparity in health across
SES groups [28]. However, no systematic program has
been implemented at the national or regional level to re-
duce disparities in health. Previously, the publication of
data from a systematic analysis of quality indicators lead
to a reduction in the SES differential in mortality in eld-
erly patients with hip fracture [29]. A relevant result
from the present study is the reduction in the SES differ-
ential in survival when patients are “exposed” to the
optimal pathway of care in comparison to low-quality
pathways of care. This suggests that implementing strat-
egies to promote high quality of care in the overall
population may lead to an improvement in health for
more vulnerable people. The residual level of differences
in survival observed in patients “exposed” to the best
care-pathways may be attributed to individual clinical,
behavioral or contextual risk factors.
We also evaluated the pattern of association according
to sex and age. The impact of care-pathway quality on
the association between education level and 1-year sur-
vival was the same for men and women, confirming pre-
vious findings [30]. For younger patients, we observed
almost the same socioeconomic differential in mortality
according to different scenarios of care-pathways, while
in older patients, the social inequality was higher among
those who received the worst care-pathway. This can be
interpreted as a greater level of susceptibility to a low
level of care among disadvantaged old people because of
their higher prevalence of multiple concomitant diseases
and unfavorable behavioral and situational risk factors.
The strengths of our study include the population-
based study design, the large number of patients, the use
of an integrated measure of care retrieved from different
sources, the multilevel statistical approach, and the
measurement of a synthetic value of probability to
survive using information from both the acute and post-
acute phases. Some limitations should also be recog-
nized. First, the level of education was obtained from the
discharge documents, and we did not have information
on its accuracy. However, in a previous study in our
region, the validity of this measure was evaluated, and
they estimated that it was good [31]. Second, drug use
data from our health data warehouse refer to the pre-
scribed agents, but the actual levels of intake cannot be
evaluated, as in all studies that use this information [32].
Third, the potential limitation of the statistical approach
was considered; to test the robustness of the results, we
performed the analysis using different statistical methods,
and the results were sufficiently confirmed.
Conclusions
This study demonstrated the real-life effectiveness of
evidence-based interventions for stroke patients,
highlighting the persistent differences in survival across
SES groups even when taking into account quality of
care. However, the findings emphasize the importance of
improving the quality of a care as a tool to reduce health
disparities.
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